Significant Pharmaceuticals Reported in US Patents

Significant Pharmaceuticals Reported in US Patents

1st Edition - May 2, 2007

Write a review

  • Author: Thomas F. DeRosa
  • eBook ISBN: 9780080480916

Purchase options

Purchase options
DRM-free (EPub, Mobi, PDF)
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order

Description

Significant Pharmaceuticals Reported in US Patents identifies the next generation of pharmaceuticals reported in US Patents. This "hands-on" title provides explicit laboratory methods for preparing the most recent and effective medications. Each entry documents the biological testing protocols used to evaluate a drug and the significance of the current treatment agent over previous methods. Pharmaceuticals are included in this review only if at least two of the following criteria were met: Effectiveness in treating an illness, Innovative, ease of preparation, synergy with existing Medications. Pharmaceuticals are reported for 27 separate classes of illness, including: AIDS, Alzheimer's Disease, Cardiovascular Disorders, Diabetes, Epilepsy, Hepatitis C, Osteoporosis, Obesity and Sleep Disorders. Significant Pharmaceuticals Reported in US Patents has been designed to be used as both a reference and synthetic guide for pharmaceutical, medicinal and organic chemists and graduate students. Researchers working in other areas will also find the information valuable as in many instances intermediates or the next generation pharmaceutical are readily convertible into other industrial products including: anti-oxidants, chemical additives, herbicides, polymer precursors, water purification agents. Clear structural depictions of reagents and chemical transformations have been supplied to permit the identification of other future applications.

Key Features

  • Identifies next generation pharmaceuticals
  • Provides practical preparation methods for each active agent and derivatives
  • Documents the analytical characterization and biological testing results of active agents

Readership

For academic, government, and industrial researchers interested in organic chemistry, medicinal chemistry, natural products, pharmaceuticals, pharmacology and structure-property relationships.

Table of Contents

  • Acquired Immune Deficiency Syndrome

    Addiction Disorders

    Alzheimer's Disease

    Analgesics

    Antibacterial Agents

    Anti-inflammatory Agents

    Autoimmune Disorders

    Cardiovascular Disorders

    Diabetes

    Diagnostics

    Epilepsy

    Gastrointestional Disorders

    Hepatitis C

    Hormonal Disorders

    Immunosuppressants

    Improved Synthetic Methods

    Incontinence

    Irritable Bowel Syndrome

    Osteoporosis

    Malaria

    Migraine Headaches

    Obesity

    Proliferative Disorders

    Skin Disorders

    Sleep Disorders

    Thyroid Disorders

    Tinnitus

Product details

  • No. of pages: 700
  • Language: English
  • Copyright: © Elsevier Science 2007
  • Published: May 2, 2007
  • Imprint: Elsevier Science
  • eBook ISBN: 9780080480916

About the Author

Thomas F. DeRosa

Dr. DeRosa has a Ph.D. in Organic/Polymer Chemistry from the Polytechnic Institute of New York. He is the author of multiple books on Chemistry including Next Generation of International Chemical Additives: A Critical Review of Current US Patents (Elsevier, 2012, 9780444537881), Significant Pharmaceuticals Reported in US Patents (Elsevier Science, 2007, 9780080480916), and Advances in Synthetic Organic Chemistry and Methods Reported in US Patents (Elsevier Science, 2006, 9780080455631), has published 14 peer-reviewed papers and has been issued 47 US Patents associated with chemical additives.

Affiliations and Expertise

Southbury, Connecticut, USA

Ratings and Reviews

Write a review

There are currently no reviews for "Significant Pharmaceuticals Reported in US Patents"